Skip to main content
. 2014 Dec 11;29(1):139–146. doi: 10.1080/13102818.2014.989727

Figure 4.

Figure 4.

Effects of drug administration on pathogenic changes in DKD patients. Note: A 12 week period of irbesartan administration alone (DI) or combination treatment with TwHF/irbesartan (DTI). The urinary excretion of proteins (A) and podocytes (B) and the ratio of podocytes/serum creatinine (Scr) were detected before and after drug administration.